Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma

Clinical trial NCT01856192 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT01856192

Sponsor

National Cancer Institute (NCI)

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2013-08-27

Primary completion

2020-03-26

Enrollment

349

View on ClinicalTrials.gov